Sanders to Announce New Information on the Production and Pricing of Blockbuster Diabetes and Weight-Loss Drugs Ozempic and Wegovy at Expert Discussion
WASHINGTON, Sept. 16 – Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), tomorrow will hold a discussion with experts on the outrageously high cost of diabetes and weight-loss drugs in America. At the meeting – which comes ahead of the committee hearing Sanders will be leading next week on the same issue – Sanders will announce new information about discussions he has had with major pharma companies on the production and pricing of blockbuster drugs Ozempic and Wegovy.
Details
What: Expert Discussion with Chairman Sanders on the Outrageous Cost of Ozempic and Wegovy in America
When: 10:30 a.m., Tuesday, September 17, 2024
Where: Room 562 Dirksen Senate Office Building. The discussion will also be livestreamed on the Sanders’ social media.
Who:
- Dale Folwell, CPA, State Treasurer of North Carolina
- Alison Galvani, PhD, Professor, Yale University
- Kristen Whitney Daniels, Co-Lead, T1International
- Reshma Ramachandran, MD, MPP, MHS, Doctors for America National
- Leader and Yale Primary Care Physician
- Melissa Barber, PhD, Postdoctoral Fellow, Yale University
